New T1 classification
| Autor: | Peter M F Lin, Michael K Hsin |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Lung Neoplasms Adenocarcinoma of Lung Adenocarcinoma in Situ 030204 cardiovascular system & hematology Adenocarcinoma Medical Oncology 03 medical and health sciences 0302 clinical medicine Surgical oncology medicine Humans skin and connective tissue diseases Lung cancer Pathological Neoplasm Staging Tumour node metastasis business.industry General Medicine medicine.disease Prognosis Cardiac surgery Cardiothoracic surgery 030220 oncology & carcinogenesis Surgery Lepidic Predominant Adenocarcinoma sense organs Radiology Cardiology and Cardiovascular Medicine business |
| Zdroj: | General thoracic and cardiovascular surgery. 68(7) |
| ISSN: | 1863-6713 |
| Popis: | The IASLC staging and Prognostic Factor Committee proposed new changes to the descriptors for the 8th edition of the Tumour Node Metastasis Staging for Lung Cancer. The T1 descriptor changes include (1) T1 tumours are subclassified into T1a ( 1 cm), T1b ( 1 to 2 cm), T1c ( 2 to 3 cm). The corresponding changes are introduced to the overall staging: T1aN0M0 = Stage IA1; T1bN0M0 = Stage IA2; T1cN0M0 = Stage IA3. (2) The introduction of the pathological entities Adenocarcinoma-In-Situ (AIS), Minimally Invasive Adenocarcinoma, and Lepidic Predominant Adenocarcinoma. The corresponding changes on the T descriptor are as follows: Adenocarcinoma-in situ is coded as Tis (AIS); Minimally Invasive Adenocarcinoma is coded as T1a(mi). In this review, the basis for these changes will be described, and the implications on clinical practice will be discussed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink